FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to therapy and cardiology. Following parameters are determined in the patient during the clinical-laboratory and instrumental examination: Charlson comorbidity index, expressed in points, value of C-reactive protein, expressed in milligrams per litre, and the area of the right atrium, expressed in square centimeters. Probability of developing atrial fibrillation (p) is calculated by original formula in %. If p > 19%, a high probability of developing atrial fibrillation is predicted.
EFFECT: method enables higher accuracy of prediction of probability of atrial fibrillation and classification by degree of risk of atrial fibrillation in comorbid patients with arterial hypertension and chronic obstructive pulmonary disease receiving treatment in hospital.
1 cl, 1 dwg, 1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR EVALUATING THE UNFAVORABLE COURSE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ARTERIAL HYPERTENSION WHEN COMBINED | 2018 |
|
RU2711453C1 |
| METHOD FOR PREDICTING COMPLICATIONS IN PATIENTS WITH CHRONIC HEART FAILURE AFTER CARDIAC SURGERIES WITH ARTIFICIAL CIRCULATION | 2017 |
|
RU2680602C1 |
| METHOD OF DETERMINING OPERABILITY OF PATIENTS SUFFERING OESOPHAGEAL CANCER | 2019 |
|
RU2718290C1 |
| PREDICTION METHOD OF ARTERIAL HYPERTENSION COMORBIDE FORM AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE DEVELOPMENT | 2016 |
|
RU2620566C1 |
| METHOD FOR PREDICTION OF RISK OF EARLY ABDOMINAL COMPLICATIONS IN PATIENTS AFTER CORRECTION OF ACQUIRED HEART DISEASES IN CONDITIONS OF ARTIFICIAL CIRCULATION | 2020 |
|
RU2734056C1 |
| METHOD FOR PREDICTING THE RISK OF LATE FATAL CARDIAC AND CEREBROVASCULAR EVENTS AFTER A PLANNED ENDOVASCULAR MYOCARDIAL REVASCULARIZATION | 2018 |
|
RU2683691C1 |
| METHOD FOR PREDICTING THE PROBABILITY OF AN UNFAVORABLE OUTCOME IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE, TUBERCULOSIS AND COMORBID CARDIOVASCULAR PATHOLOGY | 2022 |
|
RU2788897C1 |
| METHOD FOR PREDICTION OF DEVELOPING COMORBID ARTERIAL HYPERTENSION IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2024 |
|
RU2833137C1 |
| METHOD OF ASSESSING INDIVIDUAL RISK OF BARIATRIC SURGERY | 2022 |
|
RU2802387C1 |
| METHOD FOR ASSESSING THE RESIDUAL MODIFIABLE RISK OF CARDIOVASCULAR COMPLICATIONS DURING PHARMACOTHERAPY IN PATIENTS WITH STABLE EXERTIONAL ANGINA | 2022 |
|
RU2794848C1 |
